Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Study of Diafer (5% Iron Isomaltoside 1000) Administered According to Standard Hospital Practice and Product Labelling in Subjects With Chronic Kidney Disease on Haemodialysis for Treatment of Iron Deficiency

NCT02301026 is registered in ClinicalTrials.gov with Pharmacosmos A/S as lead sponsor.

NCT NCT02301026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02301026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Study of Diafer (5% Iron Isomaltoside 1000) Administered According to Standard Hospital Practice and Product Labelling in Subjects With Chronic Kidney Disease on Haemodialysis for Treatment of Iron Deficiency
Lead sponsor
Pharmacosmos A/S
Phase
Observational
Overall status
Completed
Start date
September 1, 2014
Completion date
December 9, 2016
Enrollment
209 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anaemia in chronic kidney disease